FindTrial
Sign In

Prognostic significance of the Neutrophil-to-lymphocyte ratio with Distal Cholangiocarcinoma Patients

Role of NLR with Distal Cholangiocarcinoma patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900023165
Enrollment
Unknown
Registered
2019-05-14
Start date
2019-05-01
Completion date
Unknown
Last updated
2019-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Distal Cholangiocarcinoma Patients

Interventions

Case series:none

Sponsors

Hao Zou
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Clinical information was complete; 2) All patients underwent radical surgery, and diagnosed as DCC by postoperative pathology.

Exclusion criteria

Exclusion criteria: 1) Patients underwent palliative surgery; 2) Patients with preoperative or postoperative history of radiotherapy and chemotherapy; 3) The patients were diagnosed as ampulla carcinoma; 4) The patients died within 30 days after surgery.

Design outcomes

Primary

MeasureTime frame
Neutrophil-to-lymphocyte ratio;—

Countries

China

Contacts

Public ContactHao Zou

The Second Affiliated Hospital of Kunming Medical University

jfmmay@163.com+86 15877923958

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026